Literature DB >> 21994139

Induced hyperammonemia may compromise the ability to generate restful sleep in patients with cirrhosis.

Alessia Bersagliere1, Iolanda D Raduazzo, Mariateresa Nardi, Sami Schiff, Angelo Gatta, Piero Amodio, Peter Achermann, Sara Montagnese.   

Abstract

UNLABELLED: In patients with cirrhosis, hyperammonemia and hepatic encephalopathy are common after gastrointestinal bleeding and can be simulated by an amino acid challenge (AAC), or the administration of a mixture of amino acids mimicking the composition of hemoglobin. The aim of this study was to investigate the clinical, psychometric, and wake-/sleep-electroencephalogram (EEG) correlates of induced hyperammonemia. Ten patients with cirrhosis and 10 matched healthy volunteers underwent: (1) 8-day sleep quality/timing monitoring; (2) neuropsychiatric assessment at baseline/after AAC; (3) hourly ammonia/subjective sleepiness assessment for 8 hours after AAC; (4) sleep EEG recordings (nap opportunity: 17:00-19:00) at baseline/after AAC. Neuropsychiatric performance was scored according to age-/education-adjusted Italian norms. Sleep stages were scored visually for 20-second epochs; power density spectra were calculated for consecutive 20-second epochs and average spectra determined for consolidated episodes of non-rapid eye movement (non-REM) sleep of minimal common length. The AAC resulted in: (i) an increase in ammonia concentrations/subjective sleepiness in both patients and healthy volunteers; (ii) a worsening of neuropsychiatric performance (wake EEG slowing) in two (20%) patients and none of the healthy volunteers; (iii) an increase in the length of non-REM sleep in healthy volunteers [49.3 (26.6) versus 30.4 (15.6) min; P = 0.08]; (iv) a decrease in the sleep EEG beta power (fast activity) in the healthy volunteers; (v) a decrease in the sleep EEG delta power in patients.
CONCLUSION: AAC led to a significant increase in daytime subjective sleepiness and changes in the EEG architecture of a subsequent sleep episode in patients with cirrhosis, pointing to a reduced ability to produce restorative sleep.
Copyright © 2011 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21994139     DOI: 10.1002/hep.24741

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  19 in total

1.  Effects of obstructive sleep apnea on sleep quality, cognition, and driving performance in patients with cirrhosis.

Authors:  Jasmohan S Bajaj; Leroy R Thacker; David Leszczyszyn; Samuel A Taylor; Douglas M Heuman; Shekar Raman; Richard K Sterling; Muhammad S Siddiqui; R Todd Stravitz; Arun J Sanyal; Puneet Puri; Velimir Luketic; Scott Matherly; Michael Fuchs; Melanie B White; Nicole A Noble; Ariel B Unser; James B Wade
Journal:  Clin Gastroenterol Hepatol       Date:  2014-08-23       Impact factor: 11.382

Review 2.  Hepatic encephalopathy and sleepiness: an interesting connection?

Authors:  Sara Montagnese; Matteo Turco; Piero Amodio
Journal:  J Clin Exp Hepatol       Date:  2014-06-29

3.  Sleep disturbances in patients of liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.

Authors:  Jatinderpal Singh; Barjesh Chander Sharma; Vinod Puri; Sanjeev Sachdeva; Siddharth Srivastava
Journal:  Metab Brain Dis       Date:  2017-01-09       Impact factor: 3.584

4.  Most Individuals With Advanced Cirrhosis Have Sleep Disturbances, Which Are Associated With Poor Quality of Life.

Authors:  Marwan Ghabril; Mollie Jackson; Raghavender Gotur; Regina Weber; Eric Orman; Raj Vuppalanchi; Naga Chalasani
Journal:  Clin Gastroenterol Hepatol       Date:  2017-02-03       Impact factor: 11.382

5.  Correlation between degree and quality of sleep disturbance and the level of neuropsychiatric impairment in patients with liver cirrhosis.

Authors:  Jayanta Samanta; Radha K Dhiman; Amit Khatri; Kiran K Thumburu; Sandeep Grover; Ajay Duseja; Yogesh Chawla
Journal:  Metab Brain Dis       Date:  2013-03-15       Impact factor: 3.584

6.  Vigilance and wake EEG architecture in simulated hyperammonaemia: a pilot study on the effects of L-Ornithine-L-Aspartate (LOLA) and caffeine.

Authors:  Maria Garrido; Jelena Skorucak; Daniela Raduazzo; Matteo Turco; Giuseppe Spinelli; Paolo Angeli; Piero Amodio; Peter Achermann; Sara Montagnese
Journal:  Metab Brain Dis       Date:  2016-05-19       Impact factor: 3.584

7.  Acute hyperammonaemia induces a sustained decrease in vigilance, which is modulated by caffeine.

Authors:  E P Casula; P S Bisiacchi; M Corrias; S Schiff; C Merkel; P Amodio; S Montagnese
Journal:  Metab Brain Dis       Date:  2014-07-24       Impact factor: 3.584

8.  Predictive value of induced hyperammonaemia and neuropsychiatric profiling in relation to the occurrence of post-TIPS hepatic encephalopathy.

Authors:  Marco Senzolo; Lisa Zarantonello; Chiara Formentin; Costanza Orlando; Raffaello Beltrame; Anna Vuerich; Paolo Angeli; Patrizia Burra; Sara Montagnese
Journal:  Metab Brain Dis       Date:  2019-09-10       Impact factor: 3.584

9.  Brain oscillatory activity during sleep shows unknown dysfunctions in early encephalopathy.

Authors:  María Elena Martino; José Fernández-Lorente; María Romero-Vives; Rafael Bárcena; José María Gaztelu
Journal:  J Physiol Biochem       Date:  2014-07-30       Impact factor: 4.158

10.  Excessive daytime sleepiness and hepatic encephalopathy: it is worth asking.

Authors:  Michele De Rui; Sami Schiff; Daniele Aprile; Paolo Angeli; Giancarlo Bombonato; Massimo Bolognesi; David Sacerdoti; Angelo Gatta; Carlo Merkel; Piero Amodio; Sara Montagnese
Journal:  Metab Brain Dis       Date:  2012-11-18       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.